Back to Search
Start Over
Biomarkers in advanced heart failure: diagnostic and therapeutic insights.
- Source :
-
Congestive heart failure (Greenwich, Conn.) [Congest Heart Fail] 2011 Jul-Aug; Vol. 17 (4), pp. 169-74. Date of Electronic Publication: 2011 Jul 21. - Publication Year :
- 2011
-
Abstract
- Publications regarding the potential clinical utility of biomarker testing in the management of heart failure have been exponentially increasing over the last decade. The majority of non-cardiac biomarkers are commonly used to identify end-organ dysfunction or comorbidities. The diagnostic utility of natriuretic peptide testing has been well-established. Despite consistently demonstrating their prognostic values and some promising initial results, treatment guided by natriuretic peptide testing is still debated. Although cardiac troponins have been extensively used in diagnosis of myocardial injury, their primary use of biomarkers in advanced heart failure is prognostication and risk stratification. Congest Heart Fail. Congest Heart Fail. 2011;17:169-174. © 2011 Wiley Periodicals, Inc.<br /> (© 2011 Wiley Periodicals, Inc.)
- Subjects :
- Blood Urea Nitrogen
C-Reactive Protein analysis
Creatinine blood
Heart Failure mortality
Heart Failure physiopathology
Hospital Mortality
Humans
Liver physiopathology
Natriuretic Peptides
Neurotransmitter Agents analysis
Oxidative Stress physiology
Prognosis
Risk Assessment
Biomarkers blood
Heart Failure diagnosis
Heart Failure therapy
Troponin blood
Subjects
Details
- Language :
- English
- ISSN :
- 1751-7133
- Volume :
- 17
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Congestive heart failure (Greenwich, Conn.)
- Publication Type :
- Academic Journal
- Accession number :
- 21790966
- Full Text :
- https://doi.org/10.1111/j.1751-7133.2011.00244.x